Patents by Inventor Wei-Jan Chen

Wei-Jan Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating and/or preventing atrial fibrillation
    Patent number: 9840563
    Abstract: Disclosed herein is a method for treating and/or preventing atrial fibrillation in a subject, comprising administering to the subject a pharmaceutical composition comprising an anti-CD44 neutralizing antibody or an antigen binding portion thereof which specifically binds to the amino-terminal domain of CD44. The anti-CD44 neutralizing antibody is a monoclonal antibody. The pharmaceutical composition further includes a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: October 6, 2015
    Date of Patent: December 12, 2017
    Assignee: Chang Gung Memorial Hospital, Linkou
    Inventors: Wei-Jan Chen, Yung-Hsinn Yeh, Shang-Hung Chang
  • METHOD FOR TREATING AND/OR PREVENTING ATRIAL FIBRILLATION
    Publication number: 20160215057
    Abstract: Disclosed herein is a method for treating and/or preventing atrial fibrillation in a subject, comprising administering to the subject a pharmaceutical composition comprising an anti-CD44 neutralizing antibody or an antigen binding portion thereof which specifically binds to the amino-terminal domain of CD44. The anti-CD44 neutralizing antibody is a monoclonal antibody. The pharmaceutical composition further includes a pharmaceutically acceptable carrier.
    Type: Application
    Filed: October 6, 2015
    Publication date: July 28, 2016
    Inventors: Wei-Jan Chen, Yung-Hsinn Yeh, Shang-Hung Chang
  • Prevention of atherosclerosis and restenosis
    Patent number: 6939863
    Abstract: The present application concerns pharmaceutical compositions, methods of use thereof and medical devices for preventing or treating atherosclerosiss or restenosis or both. The present invention discloses a pharmaceutical composition, including a pharmaceutically acceptable carrier and PTU in an amount sufficient to prevent atherosclerosis or restenosis in a subject. The present invention further discloses a method of inhibiting atherosclerosis or restenosis in a subject, including identifying a subject suspected of needing inhibition of atherosclerosis or restenosis and administering to the subject PTU in an amount sufficient to prevent atherosclerosis or restenosis in the subject. The present invention further discloses an article of manufacture including a medical device and PTU.
    Type: Grant
    Filed: October 16, 2002
    Date of Patent: September 6, 2005
    Inventor: Wei-Jan Chen
  • Prevention of atherosclerosis and restenosis
    Publication number: 20030130228
    Abstract: The present application concerns pharmaceutical compositions, methods of use thereof and medical devices for preventing or treating atherosclerosiss or restenosis or both. The present invention discloses a pharmaceutical composition, including a pharmaceutically acceptable carrier and PTU in an amount sufficient to prevent atherosclerosis or restenosis in a subject. The present invention further discloses a method of inhibiting atherosclerosis or restenosis in a subject, including identifying a subject suspected of needing inhibition of atherosclerosis or restenosis and administering to the subject PTU in an amount sufficient to prevent atherosclerosis or restenosis in the subject. The present invention further discloses an article of manufacture including a medical device and PTU.
    Type: Application
    Filed: October 16, 2002
    Publication date: July 10, 2003
    Inventor: Wei-Jan Chen